Implied Volatility Surging for Cardiff Oncology (CRDF) Stock OptionsZacks Investment Research • 01/19/21
Cardiff Oncology Presents Data that Continues to Demonstrate the Clinical Benefit of Onvansertib in KRAS-Mutated mCRC and Initial Findings from its Expanded Access ProgramPRNewsWire • 01/15/21
Cardiff Oncology Announces the Appointment of Dr. Rodney Markin as Chairman of the BoardPRNewsWire • 12/21/20
Cardiff Oncology Presents Data at ASH Demonstrating the Safety and Anti-Leukemic Activity of Onvansertib in Patients with Relapsed/Refractory AMLPRNewsWire • 12/06/20
Cardiff Oncology's Onvansertib Could Possibly End Up Being A Solid Cancer DrugSeeking Alpha • 10/12/20
Cardiff Oncology to Present Data Further Demonstrating the Safety and Efficacy of Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer PatientsPRNewsWire • 09/14/20